A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging

• Nakajima, Kenichi

• Nakata, Tomoaki

• Yamada, Takahisa

• Yamashina, Shohei

• Momose, Mitsuru

• Kasama, Shu

• Matsui, Toshiki

• Matsuo, Shinro

• Travin, Mark I.

• Jacobson, Arnold F.

抄録

Purpose Prediction of mortality risk is important in the management of chronic heart failure (CHF). The aim of this study was to create a prediction model for 5-year cardiac death including assessment of cardiac sympathetic innervation using data from a multicenter cohort study in Japan. Methods The original pooled database consisted of cohort studies from six sites in Japan. A total of 933 CHF patients who underwent 123I-metaiodobenzylguanidine (MIBG) imaging and whose 5-year outcomes were known were selected from this database. The late MIBG heart-to-mediastinum ratio (HMR) was used for quantification of cardiac uptake. Cox proportional hazard and logistic regression analyses were used to select appropriate variables for predicting 5-year cardiac mortality. The formula for predicting 5-year mortality was created using a logistic regression model. Results During the 5-year follow-up, 205 patients (22 %) died of a cardiac event including heart failure death, sudden cardiac death and fatal acute myocardial infarction (64 %, 30 % and 6 %, respectively). Multivariate logistic analysis selected four parameters, including New York Heart Association (NYHA) functional class, age, gender and left ventricular ejection fraction, without HMR (model 1) and five parameters with the addition of HMR (model 2). The net reclassification improvement analysis for all subjects was 13.8 % (p < 0.0001) by including HMR and its inclusion was most effective in the downward reclassification of low-risk patients. Nomograms for predicting 5-year cardiac mortality were created from the five-parameter regression model. Conclusion Cardiac MIBG imaging had a significant additive value for predicting cardiac mortality. The prediction formula and nomograms can be used for risk stratifying in patients with CHF. © 2014 The Author(s).

Article in press

This article has Supplemental materrial and methods.

収録刊行物

• European Journal of Nuclear Medicine and Molecular Imaging

  European Journal of Nuclear Medicine and Molecular Imaging 41 (9), 1673-1682, 2014-09-01

  Springer Verlag

キーワード

• 123I-Metaiodobenzylguanidine (MIBG)
• Cardiac mortality
• Chronic heart failure
• Prediction model
• Risk stratification

詳細情報

• CRID: 1050001335950948992
• NII論文ID: 120005440314
• NII書誌ID: AA1161516X
• ISSN: 16197070
• Web Site: http://hdl.handle.net/2297/37575
• 本文言語コード: en
• 資料種別: journal article
• データソース種別:
  • IRDB
  • CiNii Articles